Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma
NCT00396045
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Revlimid (CC-5013)
Sponsor
University of Turin, Italy